GSE97586
Next Generation Sequencing Facilitates Quantitative Analysis of PVT1 mutant alleles have distinct growth advatage which was introduced by CRISPR in MDA-MB-231 human breast cancer cell line
PVT1 deletion alleles have growth adavatage after 10 passages Overall design: Comapare allele frequency between passage 0 and 10 in competitive growth by two independent Cas9-sgRNA RNP transfection